LeadIQ logo
Learn more at LeadIQ.com

Insights

Collaborative Research Blueprint Medicines partnering with the University of Pennsylvania for developing an algorithm using machine learning to identify potential systemic mastocytosis (SM) cases presents an opportunity for collaboration in research and technology implementation.

Investment Opportunities Recent investments from Nicpartners, Allspring Global Investments, and INTRUST Bank indicate growing interest in Blueprint Medicines. This signals potential opportunities for partnerships, joint ventures, or investment collaborations.

Revenue Potential With a revenue range of $100M - 1B and significant funding of $1.3B, Blueprint Medicines demonstrates strong financial health and growth potential. This suggests lucrative sales opportunities for suppliers, service providers, and investors.

Expansion Possibilities The company's focus on developing treatments for mast cell diseases, breast cancer, and solid tumors signifies expansion opportunities into new therapeutic areas. This could open doors for partnerships, distribution agreements, and licensing deals.

Market Presence Being part of the biotechnology research industry and sharing similarities with companies like Revolution Medicines, Schrödinger, and others, Blueprint Medicines can leverage its market presence to explore strategic collaborations, acquisitions, or competitive positioning strategies.

Similar companies to Blueprint Medicines

Blueprint Medicines Tech Stack

Blueprint Medicines uses 8 technology products and services including Akamai, SAP, Salesforce, and more. Explore Blueprint Medicines's tech stack below.

  • Akamai
    Content Delivery Network
  • SAP
    Customer Relationship Management
  • Salesforce
    Customer Relationship Management
  • Veeva Vault
    Enterprise Content Management
  • Microsoft
    Miscellaneous
  • Microsoft Azure
    Platform As A Service
  • Amazon Web Services
    Platform As A Service
  • Perl
    Programming Languages

Media & News

Blueprint Medicines's Email Address Formats

Blueprint Medicines uses at least 1 format(s):
Blueprint Medicines Email FormatsExamplePercentage
FLast@blueprintmedicines.comJDoe@blueprintmedicines.com
96%
First.Last@blueprintmedicines.comJohn.Doe@blueprintmedicines.com
3%
FL@blueprintmedicines.comJD@blueprintmedicines.com
1%

Frequently Asked Questions

Where is Blueprint Medicines's headquarters located?

Minus sign iconPlus sign icon
Blueprint Medicines's main headquarters is located at 45 Sidney St Cambridge, Massachusetts 02139 US. The company has employees across 6 continents, including North AmericaEuropeAsia.

What is Blueprint Medicines's phone number?

Minus sign iconPlus sign icon
You can contact Blueprint Medicines's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Blueprint Medicines's stock symbol?

Minus sign iconPlus sign icon
Blueprint Medicines is a publicly traded company; the company's stock symbol is BPMC.

What is Blueprint Medicines's official website and social media links?

Minus sign iconPlus sign icon
Blueprint Medicines's official website is blueprintmedicines.com and has social profiles on LinkedIn.

How much revenue does Blueprint Medicines generate?

Minus sign iconPlus sign icon
As of October 2024, Blueprint Medicines's annual revenue reached $750M.

What is Blueprint Medicines's SIC code NAICS code?

Minus sign iconPlus sign icon
Blueprint Medicines's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Blueprint Medicines have currently?

Minus sign iconPlus sign icon
As of October 2024, Blueprint Medicines has approximately 731 employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: K. H.Chief Medical Officer: B. H.Chief Business Officer: H. H.. Explore Blueprint Medicines's employee directory with LeadIQ.

What industry does Blueprint Medicines belong to?

Minus sign iconPlus sign icon
Blueprint Medicines operates in the Biotechnology Research industry.

What technology does Blueprint Medicines use?

Minus sign iconPlus sign icon
Blueprint Medicines's tech stack includes AkamaiSAPSalesforceVeeva VaultMicrosoftMicrosoft AzureAmazon Web ServicesPerl.

What is Blueprint Medicines's email format?

Minus sign iconPlus sign icon
Blueprint Medicines's email format typically follows the pattern of . Find more Blueprint Medicines email formats with LeadIQ.

How much funding has Blueprint Medicines raised to date?

Minus sign iconPlus sign icon
As of October 2024, Blueprint Medicines has raised $1.3B in funding. The last funding round occurred on Jun 30, 2022 for $1.3B.

When was Blueprint Medicines founded?

Minus sign iconPlus sign icon
Blueprint Medicines was founded in 2011.
Blueprint Medicines

Blueprint Medicines

Biotechnology ResearchMassachusetts, United States501-1000 Employees

Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases including systemic mastocytosis and chronic urticaria, breast cancer and other solid tumors.

Patients are at the center of our mission. We know that in order to make a difference in their lives, we must create an environment where our employees — also known as the Blue Crew — can do their best work. Our culture of transparency, curiosity and diversity empowers us to draw upon a wide range of backgrounds and perspectives to build a conscientious team dynamic. Ideas come from every member of the Blue Crew, from the executive team to new hires. Each day, our teams commit to approach one another with respect and trust: a simple promise that fosters an inclusive and collaborative spirit.

We care deeply about the communities where we live and work, and we strive to make a profound impact where it matters most. Learn more about who we are and explore our career opportunities at https://www.blueprintmedicines.com/careers/. 

Read our community guidelines: https://www.blueprintmedicines.com/community-guidelines/.

Section iconCompany Overview

Headquarters
45 Sidney St Cambridge, Massachusetts 02139 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
BPMC
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
501-1000

Section iconFunding & Financials

  • $1.3B

    Blueprint Medicines has raised a total of $1.3B of funding over 9 rounds. Their latest funding round was raised on Jun 30, 2022 in the amount of $1.3B.

  • $100M$1B

    Blueprint Medicines's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $1.3B

    Blueprint Medicines has raised a total of $1.3B of funding over 9 rounds. Their latest funding round was raised on Jun 30, 2022 in the amount of $1.3B.

  • $100M$1B

    Blueprint Medicines's revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.